通过与顺二氨二氯铂（NSC - 119875）或柔红霉素（NSC - 82151）联合使用增强ICRF - 159（NSC - 129943）对早期L1210白血病的抗肿瘤效果。 - Suppr | 超能文献

Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).

作者信息

Woodman R J

出版信息

Cancer Chemother Rep 2. 1974 Mar;4(1):45-52.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).通过与顺二氨二氯铂（NSC - 119875）或柔红霉素（NSC - 82151）联合使用增强ICRF - 159（NSC - 129943）对早期L1210白血病的抗肿瘤效果。

Cancer Chemother Rep 2. 1974 Mar;4(1):45-52.

2

Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943).ICRF - 159（NSC - 129943）增强柔红霉素（NSC - 82151）或阿霉素（NSC - 123127）对早期小鼠L1210白血病的疗效。

Cancer Chemother Rep. 1975 Jul-Aug;59(4):689-95.

3

Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicin.对用ICRF - 159联合柔红霉素或阿霉素处理的小鼠进行的研究。

Cancer Treat Rep. 1981 Mar-Apr;65(3-4):267-76.

4

Synergistic effect of ricin in combination with daunorubicin, cis-dichlorodiammineplatinum(II) and vincristine in systemic L1210 leukemia.

Cancer Res. 1982 Jun;42(6):2152-8.

5

Letter: ICRF 159.信件：国际癌症研究基金会159号文件

Lancet. 1974 May 11;1(7863):926. doi: 10.1016/s0140-6736(74)90371-7.

6

Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).蒽环类药物对阿霉素（NSC - 123127）耐药的P388白血病亚系的活性，特别着重于烬灰红菌素A（NSC - 18334）。

Cancer Treat Rep. 1976 Jan;60(1):99-102.

7

Potentially useful combinations of chemotherapy detected in mouse tumor systems.在小鼠肿瘤系统中检测到的潜在有用的化疗组合。

Cancer Chemother Rep 2. 1974 Mar;4(1):33-43.

8

Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice.1-β-D-阿拉伯呋喃糖基胞嘧啶5'-金刚烷酸酯（NSC 117614）对L1210白血病小鼠的抗肿瘤作用。

Cancer Res. 1970 Apr;30(4):1047-54.

9

Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.1-β-D-阿拉伯呋喃糖基胞嘧啶与柔红霉素联合应用时的时间依赖性协同作用。

Cancer Res. 1974 Feb;34(2):293-7.

10

Antitumor activity of a water-insoluble compound entrapped in liposomes on L1210 leukemia in mice.包裹于脂质体中的一种水不溶性化合物对小鼠L1210白血病的抗肿瘤活性。

J Natl Cancer Inst. 1983 Jun;70(6):1081-6.

引用本文的文献

1

Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer.癌症患者化疗诱导毒性的临床及临床前调节

Drugs. 1999 Feb;57(2):133-55. doi: 10.2165/00003495-199957020-00002.